Association of Prenatal Exposure to Antiseizure Medications With Creative and Executive Function at Age 4.5 Years

Kimford J Meador1, Morris J Cohen1, David W Loring1

  • 1From the Stanford University (K.J.M.), Palo Alto, CA; Pediatric Neuropsychology International (M.J.C.), Augusta; Emory University School of Medicine (D.W.L., E.G.), Atlanta, GA; The Emmes Company (A.G.M., C.A.B., C.R., A.C.), Rockville, MD; Piedmont University (S.S.), Athens, GA; University of Minnesota (A.K.B.), Minneapolis; University of Southern California (L.A.K.), Los Angeles; Brigham and Women's Hospital (P.E.V.), Harvard Medical School, Boston, MA; Northwestern University (E.E.G.), Chicago, IL; Minnesota Epilepsy Group (J.H.), Roseville; University of Cincinnati (J.C.), OH; Wake Forest University (M.S.), Winston-Salem, NC; Northwell Health (S.T.H.), Great Neck; Columbia University (A.M.P.), New York, NY; University of Washington (J.J.T.), Seattle; and University of Pittsburgh (P.B.P.), PA.

Neurology
|May 29, 2024
PubMed

Insights

Fetal exposure to newer antiseizure medications (ASMs) in women with epilepsy (WWE) did not affect child creativity. However, executive functions showed exposure-dependent effects, particularly with levetiracetam, suggesting careful ASM dosing is crucial for fetal development.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Fetal exposure to antiseizure medications (ASMs) can impact neurodevelopment, but effects of newer ASMs on creativity and executive functions are not well understood.
  • Previous research indicated adverse effects of valproate on these functions.
  • This study investigates the impact of newer ASMs on creativity and executive functions in children exposed prenatally.

Purpose of the Study:

  • To compare creativity and executive functions in children of women with epilepsy (WWE) exposed to ASMs versus children of healthy women (HW).
  • To examine exposure-dependent effects of ASMs during the third trimester on these neurodevelopmental outcomes.
  • To assess the impact of specific ASMs, including levetiracetam, on executive functions.

Main Methods:

  • Prospective observational cohort study (Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs).
  • Assessment of creativity (Torrance Test of Creative Thinking) and executive functions (Behavior Rating Inventory of Executive Function-Preschool Version) in 4.5-year-old children.
  • Analysis of ASM exposure using concentration and defined daily dose ratios, with adjustments for confounding factors.

Main Results:

  • No significant differences in creativity or executive function were observed between children of WWE and HW.
  • No ASM exposure-dependent effects were found for creativity measures.
  • Exposure-dependent effects on executive function were identified in children of WWE, particularly with levetiracetam, based on ASM concentration and defined daily dose ratios.

Conclusions:

  • Fetal exposure to newer ASMs does not appear to affect creative thinking at 4.5 years.
  • Executive function in children exposed to ASMs in utero shows dependency on ASM exposure levels.
  • Optimizing ASM dosing to balance seizure control and minimize fetal risks, especially with medications like levetiracetam, is essential.
Abstract

Related Concept Videos

Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
33
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
55